De-risking Clinical Trials: The BIAL Phase I Trial in Foresight
Clin Pharmacol Ther
.
2022 Feb;111(2):362-365.
doi: 10.1002/cpt.2498.
Epub 2021 Dec 28.
Authors
Adam F Cohen
1
2
,
Jeroen van Smeden
2
3
4
,
David J Webb
5
Affiliations
1
DDCD Consulting, Leiden, The Netherlands.
2
Leiden University Medical Center, Leiden, The Netherlands.
3
Leiden Academic Centre for Drug Research, University of Leiden, Leiden, The Netherlands.
4
Centre for Human Drug Research, Leiden, The Netherlands.
5
Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, The University of Edinburgh, Scotland, UK.
PMID:
34962650
PMCID:
PMC9303912
DOI:
10.1002/cpt.2498
No abstract available
Publication types
Comment